Nabsys
Providence
About Nabsys
Nabsys develops semiconductor-based tools for genomic analysis. The company has pioneered the technology of electronic high-definition mapping which is capable of analyzing entire genomes, in very large fragments (100,000 bp and higher) traveling at high velocity (greater than 1 million base pairs per second). Nabsys was the first company to receive a “1000 Genome” award from the National Human Genome Research Institute of the National Institutes of Health for an electronic approach to DNA analysis. It was founded in 2004 and headquartered in Providence, Rhode Island.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $143.3M
- Funding stage: M&A
- Last round: Corporate Round (Nov 2022)
- Website: nabsys.com
- Phone: 401-276-9100
Industries & Categories
Biotechnology, Genetics, Health Care, Medical
Social Profiles
Canonical: https://fsome.com/organization/nabsys-62692 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.